Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New safety data supports continuation of Affymax's phase III program for Hematide

Nov. 12, 2009

Hematide is safe and increases Hb levels in CKD patients on hemodialysis

Nov. 12, 2009

Xoma initiates phase II trial of XOMA-052 IL-1beta antibody in type 1 diabetes

Nov. 11, 2009

Bristol-Myers Squibb CB1 antagonists reduce weight in obesity models

Nov. 11, 2009

Midodrine can reverse anejaculation

Nov. 11, 2009

IRM claims GDIR ligands for the treatment of diabetes and obesity

Nov. 10, 2009

Tesofensine effects on weight lead to phase III investigation

Nov. 10, 2009

Bupropion improves hypoactive sexual desire disorder in women

Nov. 10, 2009

FDA grants priority review to Shire's NDA for velaglucerase alfa in Gaucher disease

Nov. 10, 2009

Dipeptidyl peptidase IV inhibitors claimed by Taiwanese scientists as antidiabetics

Nov. 9, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...